Mereo BioPharma Group Plc (MREO)
0.3066
0.00 (0.00%)
USD |
NASDAQ |
Nov 13, 16:00
0.30
-0.01
(-2.15%)
After-Hours: 19:59
Mereo BioPharma Group Shareholders Equity (Quarterly) : 23.71M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 23.71M |
| June 30, 2026 | 28.65M |
| March 31, 2026 | 34.05M |
| December 31, 2025 | 40.92M |
| September 30, 2025 | 46.60M |
| June 30, 2025 | 54.18M |
| Date | Value |
|---|---|
| March 31, 2025 | 60.08M |
| December 31, 2024 | 60.97M |
| September 30, 2024 | 72.54M |
| June 30, 2024 | 78.65M |
| March 31, 2024 | 42.84M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 26.89M |
| BioNTech SE | 20.12B |
| Silence Therapeutics Plc | -- |
| Autolus Therapeutics Plc | 27.40M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 29.58M |
| Total Liabilities (Quarterly) | 5.872M |
| Debt to Equity Ratio | 0.0243 |
| Current Ratio | 5.219 |
| Net Debt Paydown Yield | 0.01% |